1,084 results on '"Geisbert, Thomas W."'
Search Results
152. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses
153. 164 - Marburg and Ebola Virus Hemorrhagic Fevers
154. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
155. Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR
156. Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization
157. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
158. Functional cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
159. Framework for leadership and training of Biosafety Level 4 laboratory workers
160. Filovirus infection induces an anti-inflammatory state in Rousettus bats
161. Additional file 1 of Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
162. Panmicrobial oligonucleotide array for diagnosis of infectious diseases
163. Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein
164. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
165. Immune protection of nonhuman primates against ebola virus with single low-dose adenovirus vectors encoding modified GPs
166. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment
167. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fevers
168. Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail
169. Exotic emerging viral diseases: progress and challenges
170. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein
171. Establishment of an African green monkey model for COVID-19 and protection against re-infection
172. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
173. Viral Hemorrhagic Fevers
174. Responses to Ebola and Marburg Virus Infections
175. Evaluation in nonhuman primates of vaccines against Ebola virus. (Perspectives)
176. Use of reverse genetics to inform Ebola outbreak responses
177. Progress in filovirus vaccine development: evaluating the potential for clinical use
178. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
179. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
180. Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis
181. Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
182. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
183. Author Reply to Peer Reviews of Marburg and Ebola virus infections elicit a complex, muted inflammatory state in bats
184. Neutralizing Antibodies against Crimean–Congo Hemorrhagic Fever Virus Derived from a Human Survivor
185. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques
186. Establishment of an African green monkey model for COVID-19
187. Ebola
188. Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus
189. Marburg and Ebola virus infections elicit a muted inflammatory state in bats
190. Prior vaccination with the rVSV-ZEBOV vaccine does not interfere with but improves the efficacy of postexposure antibody treatment in nonhuman primates exposed to Ebola virus
191. Correction for Satterfield et al., “Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets”
192. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38
193. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
194. Ebola and Marburg Virus Infection in Bats Induces a Systemic Response
195. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death
196. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity
197. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
198. Development of vaccines for Marburg hemorrhagic fever
199. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient
200. Development of treatment strategies to combat Ebola and Marburg viruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.